Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04613557 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04613557
- Sponsor
- Celyad Oncology SA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-16
- Primary completion
- 2022-12-21
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.